Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol
In Brief: Harold Moses Directs Vanderbilt Cancer Center; Carl Fretts, NIH contracts Director, To Retire
Interactive R01 Scores Vary widely, Result Of separate Review
Fisher, Bonadonna, Croce, Hanafusa Win GAM Cancer Prizes
ASCO Honors Holland, Koop, Monaco With Special Awards
ONS To Fund 21 Grants In ’94 Deadline Dec. 1
Prevention & Control Study Section Needed: Letter to the Editor
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ









